Basic Information
| LncRNA/CircRNA Name | circCEP128 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, RIP, western blot |
| Sample | bladder tumor tissues |
| Expression Pattern | up-regulated |
| Function Description | CircCEP128 and MYD88 were overexpressed in bladder cancer based on microarray analysis and miR-145-5p was a potential targeting factor in bladder cancer. |
| Pubmed ID | 30939216 |
| Year | 2019 |
| Title | Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway. |
External Links
| Links for circCEP128 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |